ctrl K

AI Score

Unlock

Acumen Pharmaceuticals In... (ABOS)

AI Score

Unlock

1.22

-0.06 (-4.69%)

At close: Mar 03, 2025, 11:47 AM

Acumen Pharmaceuticals Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	n/a	n/a	n/a	1.44M	1.7M
Cost of Revenue	42.32M	169K	4K	8K	8.58K
Gross Profit	-42.32M	-169K	-4K	1.43M	1.69M
Operating Income	-61.14M	-45.24M	61.57M	-7.91M	-7.8M
Interest Income	10.21M	2.39M	84K	1K	45K
Pretax Income	-52.37M	-42.86M	-100.61M	-7.33M	-7.91M
Net Income	-52.37M	-40.48M	-181.68M	-7.32M	-7.86M
Selling & General & Admin	18.82M	12.88M	7.28M	1.35M	926K
Research & Development	42.32M	32.36M	12.3M	8M	8.58M
Other Expenses	n/a	-11K	51K	n/a	n/a
Operating Expenses	61.14M	45.24M	19.58M	9.35M	9.5M
Interest Expense	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	61.14M	45.24M	19.58M	9.35M	9.5M
Income Tax	n/a	-2.38M	81.07M	-1K	-45K
Shares Outstanding (Basic)	48.49M	40.6M	40.47M	40.15M	40.15M
Shares Outstanding (Diluted)	48.61M	40.6M	40.47M	40.15M	40.15M
EPS (Basic)	-1.08	-1	-4.49	-0.18	-0.2
EPS (Diluted)	-1.08	-1	-4.49	-0.18	-0.2
EBITDA	-51.61M	-42.69M	61.58M	587K	119K
Depreciation & Amortization	184K	169K	4K	7.91M	7.8M